SaradaGurubhagavatulaMD

Oncology • Madison, NJ

Physician

Join to view full profile

Dr. Gurubhagavatula is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Gurubhagavatula's full profile

Already have an account?

Office
150 Park Avenue
Floor 3
Madison, NJ 07940
Is this information wrong?

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2001 - 2004
Brigham and Women's HospitalResidency, Internal Medicine, 1998 - 2001
Johns Hopkins University School of MedicineClass of 1998

Certifications & Licensure

NJ State Medical License 2006 - 2025
MA State Medical License 2000 - 2007
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Inside Jersey Top Doctors for Cancer Castle Connolly, 2012-2014
Inside Jersey Magazine Top Doctors Castle Connolly, 2012-2014
Top Doctors: New York Metro Area Castle Connolly, 2012-2014
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Join now to see all

Clinical Trials

Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC Start of enrollment: 2017 Jun 29
Terminated
Phase 2

Publications & Presentations

PubMed

85 citations
Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib
Geoffrey Liu, Sarada Gurubhagavatula, Wei Zhou, Zhaoxi Wang, Beow Y. Yeap, Kofi Asomaning, Li Su, Rebecca S. Heist, Thomas J. Lynch, David C. Christiani> ;The Pharmacogenomics Journal. 2008 Apr 1
173 citations
A phase II study of gefitinib in patients with advanced thyroid cancer.
Nathan A. Pennell, Gilbert H. Daniels, Robert I. Haddad, Douglas S. Ross, Tracey L. Evans, Lori J. Wirth, Panos Fidias, Jennifer S. Temel, Sarada Gurubhagavatula, Rebe...> ;Thyroid. 2008 Mar 14
7 citations
The role of adjuvant chemotherapy for non-small cell lung cancer.
Sarada Gurubhagavatula, Thomas J. Lynch> ;Seminars in Respiratory and Critical Care Medicine. 2005 Jun 1
99 citations
Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients
Rebecca Suk, Sarada Gurubhagavatula, Sohee Park, Wei Zhou, Li Su, Thomas J. Lynch, John C. Wain, Donna Neuberg, Geoffrey Liu, David C. Christiani> ;Clinical Cancer Research. 2005 Feb 15
233 citations
Excision Repair Cross-Complementation Group 1 Polymorphism Predicts Overall Survival in Advanced Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemot...
Wei Zhou, Sarada Gurubhagavatula, Geoffrey Liu, Sohee Park, Donna Neuberg, John C. Wain, Thomas J. Lynch, Li Su, David C. Christiani> ;Clinical Cancer Research. 2004 Aug 1
255 citations
XPD and XRCC1 Genetic Polymorphisms Are Prognostic Factors in Advanced Non—Small-Cell Lung Cancer Patients Treated With Platinum Chemotherapy
Sarada Gurubhagavatula, Geoffrey Liu, Sohee Park, Wei Zhou, Li Su, John C. Wain, Thomas J. Lynch, Donna Neuberg, David C. Christiani> ;Journal of Clinical Oncology. 2004 Jul 1
8735 citations
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A. Okimoto, Brian W. Brannigan, Patricia L. Harris, Sara M. Haserlat, Jeffrey G. Supk...> ;The New England Journal of Medicine. 2004 May 20
164 citations
Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, ‘Iressa’) on an expanded access study
Pasi A. Jänne, Sarada Gurubhagavatula, Beow Y. Yeap, Joan Lucca, Patricia Ostler, Arthur T. Skarin, Panos Fidias, Thomas J. Lynch, Bruce E. Johnson> ;Lung Cancer. 2004 May 1
58 citations
A novel presenilin-1 mutation: increased beta-amyloid and neurofibrillary changes.
Teresa Gomez-Isla, Wilma Wasco, W P Pettingell, Sarada Gurubhagavatula, Stephen D. Schmidt, P. D. Jondro, Megan J. McNamara, L A Rodes, DiBlasi T, Whitfield B. Growdon...> ;Annals of Neurology. 1997 Jun 1
90 citations
Familial Alzheimer's chromosome 14 mutations.
Wilma Wasco, W P Pettingell, P. D. Jondro, Stephen D. Schmidt, Sarada Gurubhagavatula, L A Rodes, DiBlasi T, Donna M. Romano, Suzanne Y. Guénette, Dora M. Kovacs> ;Nature Medicine. 1995 Sep 1
289 citations
Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid beta protein precursor.
Wilma Wasco, Sarada Gurubhagavatula, Marc d. Paradis, Donna M. Romano, Sangram S. Sisodia, Bradley T. Hyman, Rachael L. Neve, Rudolph E. Tanzi> ;Nature Genetics. 1993 Sep 1
20 citations
Genetic heterogeneity of gene defects responsible for familial Alzheimer disease
Rudolph E. Tanzi, Sandra M. Gaston, Ashley I. Bush, Donna M. Romano, Warren H. Pettingell, Jeffrey Peppercorn, Marc d. Paradis, Sarada Gurubhagavatula, Barbara Jenkins...> ;Genetica. 1993 Jan 1
Join now to see all